MD1339Z - Method for predicting the risk of death in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction - Google Patents
Method for predicting the risk of death in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction Download PDFInfo
- Publication number
- MD1339Z MD1339Z MDS20180116A MDS20180116A MD1339Z MD 1339 Z MD1339 Z MD 1339Z MD S20180116 A MDS20180116 A MD S20180116A MD S20180116 A MDS20180116 A MD S20180116A MD 1339 Z MD1339 Z MD 1339Z
- Authority
- MD
- Moldova
- Prior art keywords
- death
- cys
- risk
- heart failure
- determined
- Prior art date
Links
- 206010019280 Heart failures Diseases 0.000 title abstract 2
- 208000004990 Cardiorenal syndrome Diseases 0.000 title 1
- 102000012192 Cystatin C Human genes 0.000 abstract 4
- 108010061642 Cystatin C Proteins 0.000 abstract 4
- 102000001554 Hemoglobins Human genes 0.000 abstract 3
- 108010054147 Hemoglobins Proteins 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010049694 Left Ventricular Dysfunction Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002996 emotional effect Effects 0.000 abstract 1
- 230000024924 glomerular filtration Effects 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention relates to medicine, in particular to cardiology and nephrology.Summary of the invention consists in that it is conducted the clinical and paraclinical examination, where is determined the serum level of cystatin C (CYS) and the level of hemoglobin (HB), is estimated the glomerular filtration rate using a simplified formula based on cystatin C (RFG100/cys), is determined the severity of the heart failure (IC), is conducted the echocardiographic study with the assessment of left ventricular dysfunction, is determined the degree of patient mobility (MOB), the duration of cardiovascular disease (DBCV) and the presence of emotional stress (STRESS), and the discriminant function (F) is calculated by the formula:F = - 0.552 - 0.601 · RFG100/cys - 0.633 · STRESS + 1.921 · MOB + 1,450 · CYS - 0.054 · DBCV - 0.019 · HB + 0.503 · IC;in the case when F > 0 is predicted an increased risk of death, and F < 0 - a low risk of death.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20180116A MD1339Z (en) | 2018-12-06 | 2018-12-06 | Method for predicting the risk of death in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20180116A MD1339Z (en) | 2018-12-06 | 2018-12-06 | Method for predicting the risk of death in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1339Y MD1339Y (en) | 2019-06-30 |
| MD1339Z true MD1339Z (en) | 2020-01-31 |
Family
ID=67069694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20180116A MD1339Z (en) | 2018-12-06 | 2018-12-06 | Method for predicting the risk of death in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1339Z (en) |
-
2018
- 2018-12-06 MD MDS20180116A patent/MD1339Z/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD1339Y (en) | 2019-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hagan et al. | The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease | |
| Hinojosa-Laborde et al. | Validation of lower body negative pressure as an experimental model of hemorrhage | |
| Aissaoui et al. | Prediction of post-induction hypotension by point-of-care echocardiography: a prospective observational study | |
| Zakhary et al. | Predictors of mortality after extracorporeal cardiopulmonary resuscitation | |
| Kemp et al. | Insulin resistance and carotid intima-media thickness mediate the association between resting-state heart rate variability and executive function: A path modelling study | |
| Cases et al. | Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology | |
| Lubas et al. | Impact of cardiovascular organ damage on cortical renal perfusion in patients with chronic renal failure | |
| MD1339Z (en) | Method for predicting the risk of death in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction | |
| MD1341Z (en) | Method for predicting the risk of vascular accidents in patients with cardiorenal syndrome type 2 and heart failure with intermediate and reduced ejection fraction | |
| Tınazlı et al. | Hyperuricemia and Fragmented QRS | |
| Al Fattah et al. | Delivery Outcome Among Pregnant Women with Hypertension | |
| Landaluce Triska et al. | MO325: Renal Glycosuria in Acute Kidney Injury Predicts the Diagnosis of Acute Interstitial Nephritis | |
| Ahmed et al. | THE INVERSE RELATIONSHIP OF PULSE PRESSURE TO LDL CHOLESTEROL IN PATIENTS WITH TYPE II DIABETES AND CKM (CARDIO KIDNEY METABOLIC) DISEASE | |
| Boran et al. | Idiopathic Costochondritis and Tietze Syndrome: Atypical Chest Pain Syndromes–Recurrence Rates, Treatment Modalities, Seasonality | |
| Bagordo et al. | NATRIURETIC RESPONSE TO SALINE LOAD IN PATIENTS WITH PRIMARY ALDOSTERONISM | |
| Wang et al. | Cinnamaldehyde attenuates high glucose-induced oxidative stress and endothelial dysfunction as an Nrf2 activator | |
| Aditya et al. | Role of pulse pressure in worsening the renal function of patient with hypertension | |
| Chia et al. | Evaluating the Effectiveness of a Pragmatic Intervention in Reducing Blood Pressure in Patients with Hypertension | |
| Mallick et al. | Value of ST-Segment Depression with T-Wave Inversion in Lateral Leads I, aVL, V4-V6 in Diagnosing the Left Main or Left Main Equivalent Coronary Artery Disease | |
| Mocan et al. | Inflammation and oxidative stress biomarkers as predictors of diastolic dysfunction in patients with metabolic syndrome | |
| Milzman et al. | 140: IMPROVED EARLY DIAGNOSIS OF TAKO-TSUBO SYNDROME: RATIO OF BNP: TROPONIN I FOR CARIOGENIC SHOCK PTS | |
| Gottsäter et al. | [OP. 7C. 03] CHARACTERISTICS OF SUBJECTS AT LOWER END OF CAROTID-FEMORAL PULSE WAVE VELOCITY DISTRIBUTION, WHY ARE THEY HEALTHY? | |
| Yashio et al. | 138: PREVALENCE OF TAKOTSUBO CARDIOMYOPATHY IN EMERGENCY DEPARTMENT | |
| Uzawa et al. | 139: TETRASTARCH SUPPRESSES VASCULAR PERMEABILITY IN AN ACUTE HEMORRHAGE MOUSE MODEL | |
| Joly et al. | Dissecting the INTERMACS Definition of Right Heart Failure: Can We Really Predict Central Venous Pressure? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| KA4Y | Short-term patent lapsed due to non-payment of fees (with right of restoration) |